UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 447

Sortiert nach

IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors

Molecular therapy, 2020-05, Vol.28 (5), p.1299-1313

2020

Volltextzugriff (PDF)

Mechanistic Studies of Alkene/CO Polymerization with Palladium Complexes Promoted by B(C6F5)3

Organometallics, 2000-04, Vol.19 (8), p.1470-1476

2000

Volltextzugriff (PDF)

Testicular cancer: Fortieth anniversary of a cancer cure

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15555-e15555

2015

Volltextzugriff (PDF)

Challenges experienced by paid carers providing palliative care to adults with intellectual disabilities

Learning disability practice, 2020-09, Vol.23 (5), p.36-45

2020

Volltextzugriff (PDF)

Impact of cannabis (CA) use on chemotherapy (C) treatment and tumor characteristics of patients (pts) with testicular germ cell tumor (TGCT): Experience of the Centre Léon Bérard (CLB)

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e16054-e16054

2019

Volltextzugriff (PDF)

Reporting burden or game-changer?

The Estates Gazette, 2022-05, p.58-58

Boyle, Jane

2022

Volltextzugriff (PDF)

Adapted physical activity and recommendations for second cancers prevention for adolescents and young adults with cancer

Journal of clinical oncology, 2018-05, Vol.36 (15_suppl), p.1518-1518

2018

Volltextzugriff (PDF)

Efficacy of antiangiogenic renal neoplasm with bone metastasis: A mono-institutional study in France

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.610-610

2018

Volltextzugriff (PDF)

Outcomes of male patients with germ cell tumors and bone metastases: A mono-institutional retrospective study

Journal of clinical oncology, 2018-02, Vol.36 (6_suppl), p.570-570

2018

Volltextzugriff (PDF)

Utility of a general molecular screening program in patients with GU malignancies: The ProfiLER trial experience

Journal of clinical oncology, 2020-02, Vol.38 (6_suppl), p.528-528

2020

Volltextzugriff (PDF)

Predictive value of hypercholesterolemia on progression free survival in patients treated with everolimus for renal cell carcinoma

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e15598-e15598

2015

Volltextzugriff (PDF)

Thromboembolic events (TE) in men treated with bleomycine-etoposide-cisplatin (BEP): A monocentric review over one year

Journal of clinical oncology, 2014-02, Vol.32 (4_suppl), p.375-375

2014

Volltextzugriff (PDF)

Spinal bone marrow necrosis after retroperitoneal lymph node dissection

The spine journal, 2016-08, Vol.16 (8), p.e509-e510

2016

Volltextzugriff (PDF)

Brain metastases in patients with urothelial carcinoma

Journal of clinical oncology, 2013-02, Vol.31 (6_suppl), p.282-282

2013

Volltextzugriff (PDF)

Prognostic value of hemoglobin level increase during axitinib treatment for metastatic renal cell carcinoma

Journal of clinical oncology, 2016-01, Vol.34 (2_suppl), p.580-580

2016

Volltextzugriff (PDF)

Impact of news drugs in the median overall survival of patients with metastatic castration resistant prostate cancer (mCRPC)

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.e16096-e16096

2013

Volltextzugriff (PDF)

Brain metastases in patients with urothelial carcinoma

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e15009-e15009

2012

Volltextzugriff (PDF)

Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution

Biology of blood and marrow transplantation, 2012-11, Vol.18 (11), p.1656-1663

2012

Volltextzugriff (PDF)

Pazopanib (P) and bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors: Phase I combination study final analysis

Journal of clinical oncology, 2013-05, Vol.31 (15_suppl), p.4574-4574

2013

Volltextzugriff (PDF)

Metastatic chromophobe renal cell carcinoma treated with target therapies: A Renal Cross Chanel Group (RCCG) study

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.4561-4561

2015

Volltextzugriff (PDF)

A comparison of the outcomes after neoadjuvant (NC) or adjuvant chemotherapy (AC) for muscle-invasive urothelial bladder cancer (UC): A French contemporary retrospective multicenter cohort

Journal of clinical oncology, 2015-03, Vol.33 (7_suppl), p.325-325

2015

Volltextzugriff (PDF)

A phase I study of pazopanib (P) combined with bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.4614-4614

2012

Volltextzugriff (PDF)

Qantas fares gives business the blues

The Australian financial review, 2003-05 (30 May 2003), p.80

Jane Boyle

2003

Volltextzugriff (PDF)

1 – 25 von 447

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(366)
Mit Volltextzugriff
(356)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(398)
Japanisch
(36)
Deutsch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

IMPDH1/YB-1 Positive Feedback Loop Assembles Cytoophidia and Represents a Therapeutic Target in Metastatic Tumors

Mechanistic Studies of Alkene/CO Polymerization with Palladium Complexes Promoted by B(C6F5)3

Testicular cancer: Fortieth anniversary of a cancer cure

Challenges experienced by paid carers providing palliative care to adults with intellectual disabilities

Impact of cannabis (CA) use on chemotherapy (C) treatment and tumor characteristics of patients (pts) with testicular germ cell tumor (TGCT): Experience of the Centre Léon Bérard (CLB)

Reporting burden or game-changer?

Adapted physical activity and recommendations for second cancers prevention for adolescents and young adults with cancer

Efficacy of antiangiogenic renal neoplasm with bone metastasis: A mono-institutional study in France

Efficacy and safety of abiraterone acetate plus prednisone and androgen deprivation therapy +/- docetaxel in older patients (≥70 years), with de novo metastatic-castration sensitive prostate cancer, compared to younger patients (<70 years): The PEACE-1 trial

Outcomes of male patients with germ cell tumors and bone metastases: A mono-institutional retrospective study

Utility of a general molecular screening program in patients with GU malignancies: The ProfiLER trial experience

Predictive value of hypercholesterolemia on progression free survival in patients treated with everolimus for renal cell carcinoma

Thromboembolic events (TE) in men treated with bleomycine-etoposide-cisplatin (BEP): A monocentric review over one year

Spinal bone marrow necrosis after retroperitoneal lymph node dissection

Brain metastases in patients with urothelial carcinoma

Prognostic value of hemoglobin level increase during axitinib treatment for metastatic renal cell carcinoma

Impact of news drugs in the median overall survival of patients with metastatic castration resistant prostate cancer (mCRPC)

Brain metastases in patients with urothelial carcinoma

Busulfan, Fludarabine, and Alemtuzumab As a Reduced Toxicity Regimen for Children with Malignant and Nonmalignant Diseases Improves Engraftment and Graft-versus-Host Disease without Delaying Immune Reconstitution

Pazopanib (P) and bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors: Phase I combination study final analysis

Pathologic down-staging following standard (SD) MVAC (methotrexate-vinblastine-doxorubicine-cisplatin) or dose-dense MVAC (DD) neoadjuvant chemotherapy (NC) for muscle-invasive urothelial bladder cancer (UC): A retrospective multicenter cohort of the French Genitourinary Tumor Group (GETUG/AFU)

Metastatic chromophobe renal cell carcinoma treated with target therapies: A Renal Cross Chanel Group (RCCG) study

A comparison of the outcomes after neoadjuvant (NC) or adjuvant chemotherapy (AC) for muscle-invasive urothelial bladder cancer (UC): A French contemporary retrospective multicenter cohort

A phase I study of pazopanib (P) combined with bevacizumab (B) in patients with metastatic renal cell carcinoma (mRCC) or other advanced refractory tumors

Qantas fares gives business the blues

Suchergebnisse filtern